Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2647 (LINC02647) is a human long intergenic non-coding RNA, classified as a lincRNA. LincRNAs are autonomously transcribed RNA molecules greater than 200 nucleotides in length that do not overlap any protein-coding genes. Their best-characterized molecular features include roles in regulating gene expression, modulating chromatin architecture, and sometimes functioning through enhancer-like activity[3][5]. Most lincRNAs—including LINC02647—remain poorly characterized, and their specific biological functions, disease associations, or drug interactions have not been functionally validated in the scientific literature to date[3]. While lincRNAs as a class are known to impact various cellular processes and diseases, there is no current evidence to specifically classify LINC02647 as a therapeutic target or to associate it with particular biological or disease roles[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2647 (LINC02647).